The global cell culture incubator market is expected to rise steadily, reaching a value of more than US$ 4,305.1 million by 2033. Building on a projected market size of US$ 2,315.5 million in 2023, this indicates a Compound Annual Growth Rate (CAGR) of 6.4%.
Explore With Your Report Sample:
https://www.futuremarketinsights.com/reports/sample/rep-gb-4392
In both clinical and biological research contexts, cell culture incubators are essential instruments. These chambers with regulated environments foster the growth of cells used in various applications, including:
- Drug Discovery and Development: Cell cultures play a critical role in testing the efficacy and safety of new medications.
- Gene Therapy Research: Incubators support the growth of genetically modified cells used in gene therapy development.
- Tissue Engineering: These devices are essential for cultivating cells used in creating functional tissues for transplants and regenerative medicine.
- In Vitro Fertilization (IVF): Precise temperature and gas control within incubators is crucial for successful embryo development during IVF procedures.
Growth Driven by Expanding Biotech Industry:
Several key factors are driving the cell culture incubator market forward:
- Booming Biotechnology Sector: The exponential growth of the biotechnology industry creates a rising demand for cell culture technology and equipment.
- Novel Applications: Continuous advancements in biotechnology are leading to the development of new and exciting applications for cell culture incubators.
- Increasing Research Funding: Growing public and private investments in biomedical research contribute to the market’s expansion.
Market Competition:
The key players of this market include Thermo Fisher Scientific Inc, Memmert GmbH + Co.KG, Binder GmbH, Panasonic, BioIVT, Sheldon Manufacturing, Inc.
- Thermo Fisher Scientific Inc. announced in June 2021 that the company’s Thermo Scientific Cytomat 24 automated incubators and storage systems are combined with the latest technology to aid increased throughput and sample protection. The new Cytomat 24 automated incubators and storage systems from Thermo Fisher Scientific, which will be available in May 2021, provide a large capacity, quick access, and a wide temperature range while minimizing contamination difficulties in high-throughput applications. The new instruments use temperature consistency and stability to assure reproducibility for cell culture applications, while also providing speedy delivery of microtiter plates via an enhanced plate shuttle system, according to a press release issued by Thermo Fisher on May 14, 2021. The system also incorporates an LED touch screen that is installed on the door for easy access and viewing.
- BioIVT released its GMP Grade Human AB Serum tailored for gene therapy manufacturing in January 2022. BioIVT’s GMP-grade human AB serum is manufactured with the same optimized processes and improved regulatory control of source material collection, manufacturing, and processing as its research-use only material. However, it also includes extra viral tests and documentation for hepatitis A (plasma-derived only), hepatitis B core antibody, hepatitis E, and parvovirus B19 (plasma-derived only).
Understand Our Methodological Process:
https://www.futuremarketinsights.com/request-report-methodology/rep-gb-4392
Key Segments Profiled In The Cell Culture Incubator Industry Survey:
By Type:
- Air-jacketed
- Water-jacketed
- Direct Heat
By Sensor Technology:
- Infra-red
- Thermal Conductivity
By Application:
- For Pharmaceutical Applications
- For Biomedical and Clinical Labs
- For Government Research
- For IVF Processes
- For Other Applications
By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East & Africa
Explore In-Depth Market Insights: Purchase Now to Access:
https://www.futuremarketinsights.com/checkout/4392
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
